International Stem Cell Co. (OTCMKTS:ISCO – Get Free Report) shares passed above its 200-day moving average during trading on Tuesday . The stock has a 200-day moving average of $0.08 and traded as high as $0.11. International Stem Cell shares last traded at $0.11, with a volume of 12,000 shares changing hands.
International Stem Cell Stock Performance
The firm has a market cap of $909,600.00, a price-to-earnings ratio of -1.42 and a beta of 0.17. The firm has a fifty day simple moving average of $0.08 and a 200-day simple moving average of $0.08.
International Stem Cell Company Profile
International Stem Cell Corporation, a clinical stage biotechnology company, focuses on the development of therapeutic and biomedical products in the United States, Asia, Europe, and internationally. It develops ISC- hpNSC, a neural stem cell program that has completed the Phase I clinical trial for the treatment of Parkinson's disease, as well as for treating stroke and traumatic brain injury.
Featured Articles
- Five stocks we like better than International Stem Cell
- Stock Dividend Cuts Happen Are You Ready?
- 5 Reasons DraftKings Stock Looks Promising in the New Year
- Stocks with Unusual Volume: How to Find Unusual Volume Stocks in Real Time
- Cybersecurity Stocks: 1 Immediate Buy and 1 Dip Opportunity
- What is a Low P/E Ratio and What Does it Tell Investors?
- The Next 2 AI Winners Have Triple-Digit Upside Potential
Receive News & Ratings for International Stem Cell Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for International Stem Cell and related companies with MarketBeat.com's FREE daily email newsletter.
